[1] |
|
[2] |
CHAMOT A M, BENHAMOU C L, KAHN M F,et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases[J]. Rev Rhum Mal Osteoartic,1987,54(3):187-196.
|
[3] |
LIU S, TANG M W, CAO Y H,et al. Synovitis,acne,pustulosis,hyperostosis,and osteitis syndrome:review and update[J]. Ther Adv Musculoskelet Dis, 2020, 12:1759720x20912865. DOI: 10.1177/1759720x20912865.
|
[4] |
|
[5] |
ZIMMERMANN P, CURTIS N. Synovitis,acne,pustulosis,hyperostosis,and osteitis (SAPHO) syndrome - a challenging diagnosis not to be missed[J]. J Infect, 2016, 72:S106-114. DOI: 10.1016/j.jinf.2016.04.030.
|
[6] |
|
[7] |
GAO S, DENG X L, ZHANG L H,et al. The comparison analysis of clinical and radiological features in SAPHO syndrome[J]. Clin Rheumatol, 2021, 40(1):349-357. DOI: 10.1007/s10067-020-05187-0.
|
[8] |
LI C, ZUO Y Z, WU N,et al. Synovitis,acne,pustulosis,hyperostosis and osteitis syndrome:a single centre study of a cohort of 164 patients[J]. Rheumatology:Oxford, 2016, 55(6):1023-1030. DOI: 10.1093/rheumatology/kew015.
|
[9] |
FERGUSON P J, LOKUTA M A, EL-SHANTI H I,et al. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype[J]. Arthritis Rheum, 2008, 58(10):3264-3269. DOI: 10.1002/art.23942.
|
[10] |
ASSMANN G, WAGNER A D, MONIKA M,et al. Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G inpatients with psoriasis,psoriatic arthritis,and SAPHO syndrome[J]. Rheumatol Int, 2010, 30(10):1273-1276. DOI: 10.1007/s00296-009-1136-8.
|
[11] |
|
[12] |
ALJUHANI F, TOURNADRE A, TATAR Z,et al. The SAPHO syndrome:a single-center study of 41 adult patients[J]. J Rheumatol, 2015, 42(2):329-334. DOI: 10.3899/jrheum.140342.
|
[13] |
|
[14] |
DEPASQUALE R, KUMAR N, LALAM R K,et al. SAPHO:what radiologists should know[J]. Clin Radiol, 2012, 67(3):195-206. DOI: 10.1016/j.crad.2011.08.014.
|
[15] |
EARWAKER J W S, COTTEN A. SAPHO:syndrome or concept? Imaging findings[J]. Skeletal Radiol, 2003, 32(6):311-327. DOI: 10.1007/s00256-003-0629-x.
|
[16] |
CAO Y H, LI C, XU W R,et al. Spinal and sacroiliac involvement in SAPHO syndrome:a single center study of a cohort of 354 patients[J]. Semin Arthritis Rheum, 2019, 48(6):990-996. DOI: 10.1016/j.semarthrit.2018.09.004.
|
[17] |
WEKELL P, BJöRNSDOTTIR H, BJöRKMAN L,et al. Neutrophils from patients with SAPHO syndrome show no signs of aberrant NADPH oxidase-dependent production of intracellular reactive oxygen species[J]. Rheumatology(Oxford), 2016, 55 (8):1489-1498. DOI: 10.1093/rheumatology/kew192.
|
[18] |
|
[19] |
|
[20] |
|
[21] |
XIANG Y R, WANG Y T, CAO Y H,et al. Tonsillitis as a possible predisposition to synovitis,acne,pustulosis,hyperostosis and osteitis(SAPHO)syndrome[J]. Int J Rheum Dis, 2021, 24(4):519-525. DOI: 10.1111/1756-185X.14064.
|
[22] |
DEVELIOGLU O N, IPEK H D, BAHAR H,et al. Bacteriological evaluation of tonsillar microbial flora according to age and tonsillar size in recurrent tonsillitis[J]. Eur Arch Otorhinolaryngol, 2014, 271(6):1661-1665. DOI: 10.1007/s00405-014-2898-5.
|
[23] |
ASSMANN G, KUECK O, KIRCHHOFF T,et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation:an interventional study[J]. Arthritis Res Ther, 2009, 11(5):R140. DOI: 10.1186/ar2812.
|
[24] |
HOFMANN S R, KAPPLUSCH F, GIRSCHICK H J,et al. Chronic recurrent multifocal osteomyelitis(CRMO):presentation,pathogenesis,and treatment[J]. Curr Osteoporos Rep, 2017, 15(6):542-554. DOI: 10.1007/s11914-017-0405-9.
|
[25] |
NAVARINI A A, BURDEN A D, CAPON F,et al. European consensus statement on phenotypes of pustular psoriasis[J]. J Eur Acad Dermatol Venereol, 2017, 31(11):1792-1799. DOI: 10.1111/jdv.14386.
|
[26] |
VEKIC D A, WOODS J, LIN P,et al. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate:a case report and review of the literature[J]. Int J Dermatol, 2018, 57 (1):10-18. DOI: 10.1111/ijd.13740.
|
[27] |
|
[28] |
GARCOVICH S, AMELIA R, MAGARELLI N,et al. Long-term treatment of severe SAPHO syndrome with adalimumab:case report and a review of the literature[J]. Am J Clin Dermatol, 2012, 13 (1):55-59. DOI: 10.2165/11593250-000000000-00000.
|
[29] |
SÁEZ-MARTíN L C, GÓMEZ-CASTRO S, ROMÁN-CURTO C,et al. Etanercept in the treatment of SAPHO syndrome[J]. Int J Dermatol, 2015, 54(6):e206-208. DOI: 10.1111/ijd.12675.
|
[30] |
DAOUSSIS D, KONSTANTOPOULOU G, KRANIOTIS P,et al. Biologics in SAPHO syndrome:a systematic review[J]. Semin Arthritis Rheum, 2019, 48(4):618-625. DOI: 10.1016/j.semarthrit.2018.04.003.
|
[31] |
BERTHELOT J M, CORVEC S, HAYEM G. SAPHO,autophagy,IL-1,FoxO1,and Propionibacterium (Cutibacterium) acnes[J]. Joint Bone Spine, 2018, 85(2):171-176. DOI: 10.1016/j.jbspin.2017.04.010.
|
[32] |
MURAKAMI M, MASUDA K, UTSUNOMIYA R,et al. Cefcapene pivoxil hydrochloride is a potentially new treatment for palmoplantar pustulosis with pustulotic arthro-osteitis[J]. Dermatology, 2015, 231(4):304-311. DOI: 10.1159/000439401.
|